Literature DB >> 12098655

Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X.

Armagan Altun1, Mevlut Yaprak, Meryem Aktoz, Arzu Vardar, Ugur Altun Betul, Gultac Ozbay.   

Abstract

We investigated nocturnal secretion pattern of melatonin in patients with cardiac syndrome X and healthy subjects. The present study performed in five patients with cardiac syndrome X and in nine healthy controls. Blood samples from all subjects were collected every 2 h intervals between 22:00 and 08:00 h. Melatonin levels were measured with a radioimmunoassay kit. Patients with cardiac syndrome X secreted less nocturnal melatonin at 02:00 h than control subjects (P=0.04). Peak and Delta melatonin (peak-lowest melatonin) were found lower in patients with cardiac syndrome X (P=0.039 and P=0.028, respectively). In conclusion patients with cardiac syndrome X show a markedly decreased nocturnal melatonin synthesis. Our study provides useful information about melatonin synthesis and release in patients with cardiac syndrome X might help physicians in managing these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098655     DOI: 10.1016/s0304-3940(02)00368-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

Review 1.  The therapeutic potential of melatonin: a review of the science.

Authors:  Samir Malhotra; Girish Sawhney; Promila Pandhi
Journal:  MedGenMed       Date:  2004-04-13

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 3.  Circadian disruption and SCN control of energy metabolism.

Authors:  Andries Kalsbeek; Frank A Scheer; Stephanie Perreau-Lenz; Susanne E La Fleur; Chun-Xia Yi; Eric Fliers; Ruud M Buijs
Journal:  FEBS Lett       Date:  2011-03-21       Impact factor: 4.124

Review 4.  Disturbed tryptophan metabolism in cardiovascular disease.

Authors:  H Mangge; I Stelzer; E Z Reininghaus; D Weghuber; T T Postolache; D Fuchs
Journal:  Curr Med Chem       Date:  2014-06       Impact factor: 4.530

5.  Decreased serum osteoprotegerin levels in patients with cardiac syndrome X.

Authors:  A Altun; B Ugur-Altun; E Tatli
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

6.  Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats.

Authors:  Irina A Vinogradova; Vladimir N Anisimov; Andrey V Bukalev; Anna V Semenchenko; Mark A Zabezhinski
Journal:  Aging (Albany NY)       Date:  2009-10-02       Impact factor: 5.682

7.  Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus-Consequences to Melatonin Dysfunction.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2013-03-12       Impact factor: 5.923

8.  Assessment of endothelial function by brachial artery flow mediated dilatation in microvascular disease.

Authors:  Otikunta Adikesava Naidu; Durgaprasad Rajasekhar; S A A Latheef
Journal:  Cardiovasc Ultrasound       Date:  2011-12-09       Impact factor: 2.062

Review 9.  Protecting the melatonin rhythm through circadian healthy light exposure.

Authors:  Maria Angeles Bonmati-Carrion; Raquel Arguelles-Prieto; Maria Jose Martinez-Madrid; Russel Reiter; Ruediger Hardeland; Maria Angeles Rol; Juan Antonio Madrid
Journal:  Int J Mol Sci       Date:  2014-12-17       Impact factor: 5.923

10.  The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgery.

Authors:  Shaghayegh Haghjooy Javanmard; Kiyan Heshmat-Ghahdarijani; Mohsen Mirmohammad-Sadeghi; Sayed Ali Sonbolestan; Amin Ziayi
Journal:  Adv Biomed Res       Date:  2016-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.